Clinical Trial Update: Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the immunogenicity of twice-annual influenza vaccination in older adults in Hong Kong.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Human

Snippet

Sponsor: The University of Hong Kong | Conditions: Influenza, Human | Phase 4 | Status: ACTIVE_NOT_RECRUITING